Market Update (NYSE:MON): Monsanto rejects Bayer’s sweetened offer, open to talks

[Reuters] – U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG, but said it was open to further talks with the German healthcare and chemicals group as well as other parties. The widely expected rejection puts pressure on Bayer to sweetens its offer, at least enough to get access to Monsanto’s books. Read more on this. , currently valued at $recting to http://finance.ya, ended trading at $. During the trading session, MON traded between $ with a trailing 52-week range being $. MON shares are currently priced at x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s x earnings multiple. Consensus earnings for the current quarter by the 0 sell-side analysts covering the stock is an estimate of $ per share, which would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. Investors should also note that the full-year EPS estimate of $ is a $0.00 worse when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $0.00 . If reported, that would be a 0.00% decrease over the year-ago quarter. Recently, d MON from to (/fi). Previously, d MON from to . When considering if perhaps the stock is under or overvalued, the average price target is $, which is 0.00% below where the stock opened this morning. See more in (NYSE:MON) Similar Articles: Market Update: Monsanto Company (NYSE:MON) – Bayer expands financing group for Monsanto bid-source Market Update: Monsanto Company (NYSE:MON) – Bayer could get ECB financing for Monsanto bid, rules show Stock Update: Monsanto Company (NYSE:MON) – Bayer defies critics with $62 billion Monsanto offer
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.